Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-March 2025. The full report is available on the Company's website. “Developmental intensity levels remain ...

US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...

Egypt's PM emphasised the partnership’s importance in bringing “advanced American equipment and expertise to Egypt” and supporting efforts to gain FDA accreditation ...